Cell and gene therapies, which involve the transfer of genetic material or cells into a patient for treatment, have been on ...
Viatris shares fell to a 52-week low after the drug company said issues related to a India facility are expected to hurt 2025 total revenue by about $500 million. The stock was recently down 14% to $9 ...
The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...
Early in the new year, the US Food and Drug Administration (FDA) released two anticipated draft guidance documents focused on artificial ...
ClearPoint's Q4 updates: neurosurgery growth, expanding services, controlled cash burn and high-potential partner programs ...
The United States Food and Drug Administration (FDA) recently released a draft guidance, Expedited Program for Serious ...
Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's ...
Hims & Hers (HIMS) stock tumbled 20% post-market after the company released its Q4 earnings report and 2025 guidance amid a ...
India's drug regulator aims to implement various reforms, including streamlining export clearances for unapproved drugs and ...
Thirty years ago, medical and psychological experts believed attention deficit hyperactivity disorder (ADHD) was a childhood ...
After years of rulemaking with impassioned input from food producers, industry stakeholders, and consumer groups, on December ...
A March meeting of outside advisers to the United States Food and Drug Administration to discuss the composition of flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results